Alphabet: Third Quarter 2021 Earnings Preview

Alphabet (NASDAQ: GOOGL) will be reporting its third quarter financial results on October 26th after the markets close. Analysts have a consensus $3,180.04 12-month price target on the company, via a total of 48 analysts, with 17 analysts having strong buy ratings. 30 analysts meanwhile have buy ratings, and 1 analyst has a sell rating on the company. The street high comes from Elazar Advisors with a $4,288.52 price target, and the lowest target sits at $1,850.

31 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 31 analysts is $63.33 billion; this number has been revised upwards from $56.61 billion at the start of April. The highest revenue estimate is $67.87 billion, while the lowest is $56.5 billion.

Onto EBITDA estimates, there are currently 26 analysts who have third-quarter EBITDA estimates. The mean is currently $25.45 billion, with this number having been revised upwards from $21.17 billion at the start of April. The street high estimate currently sits at $30.77 billion in EBITDA and the lowest is $21.85 billion.

Analysts estimate that quarterly earnings per share will come in at $23.48, with this number being revised upwards from $17.54 at the start of April. Street high is $30.67 and the lowest estimate is $19.50 per share for the quarter


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The $30,000 Gold Case Just Got Stronger | Simon Marcotte

Why Silver’s Move Is ‘Scary’ to Some Miners | Frank Basa

Are Commodities Entering a Generational Cycle? | Terry Lynch

Recommended

Steadright Closes Out Financing, Raising $1.6 Million For Moroccan Strategy

Questcorp and Riverside Lock Down Key Sonora Mineral Concessions

Related News

WELL Health: Canaccord Increases Price Target To $8.50 Following Bought Deal

This morning Canaccord Genuity raised their 12-month price target on WELL Health Technologies (TSX: WELL)...

Friday, October 23, 2020, 01:37:00 PM

Eldorado Gold: Haywood Reiterates $19.75 Price Target

On December 15th, Eldorado Gold (TSX: ELD) announced the results of the Skouries Project feasibility...

Wednesday, December 29, 2021, 03:31:00 PM

Canaccord Raises Dollarama Price Target Ahead of Results

Dollarama Inc (TSX: DOL) is expected to report its second quarter financial results on September...

Tuesday, September 7, 2021, 02:26:00 PM

Curaleaf: Canaccord Reiterates $22 Price Target Following Secured Note Issuance

On December 16th, Curaleaf Holdings (CSE: CURA) announced the closing of US$425 million 8% senior...

Thursday, December 30, 2021, 04:38:00 PM

Tesla: Canaccord Lowers Target To $812 Off 4680 Cell Delay

Tesla Inc (NASDAQ: TSLA) founder Elon Musk has been in the news quite a bit...

Monday, June 14, 2021, 05:38:00 PM